# Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

> **NCT04305834** · PHASE2 · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 43 (estimated)

## Conditions studied

- Anatomic Stage IV Breast Cancer AJCC v8
- Hormone Receptor Positive Breast Carcinoma
- Metastatic Breast Carcinoma
- Prognostic Stage IV Breast Cancer AJCC v8

## Interventions

- **DRUG:** Abemaciclib
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT04305834
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-25
- **Primary completion:** 2026-08-21
- **Final completion:** 2026-08-21
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04305834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04305834, "Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04305834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*